Ginkgo Bioworks Holdings, Inc. (DNA)
9.56
+0.16
(+1.70%)
USD |
NYSE |
Dec 09, 16:00
9.59
+0.03
(+0.31%)
Pre-Market: 20:00
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly): 559.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 503.92M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.189B |
| Total Liabilities (Quarterly) | 629.38M |
| Debt to Equity Ratio | 0.7554 |
| Current Ratio | 4.39 |
| Net Debt Paydown Yield | 0.71% |